- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
So-Young International Inc (SY)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/08/2026: SY (2-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $7.76
1 Year Target Price $7.76
| 1 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 6.89% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 260.05M USD | Price to earnings Ratio - | 1Y Target Price 7.76 |
Price to earnings Ratio - | 1Y Target Price 7.76 | ||
Volume (30-day avg) 2 | Beta 2.07 | 52 Weeks Range 0.67 - 6.28 | Updated Date 01/9/2026 |
52 Weeks Range 0.67 - 6.28 | Updated Date 01/9/2026 | ||
Dividends yield (FY) 5.26% | Basic EPS (TTM) -1.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -51.75% | Operating Margin (TTM) -18.81% |
Management Effectiveness
Return on Assets (TTM) -4.67% | Return on Equity (TTM) -34.14% |
Valuation
Trailing PE - | Forward PE 16.05 | Enterprise Value 172936731 | Price to Sales(TTM) 0.18 |
Enterprise Value 172936731 | Price to Sales(TTM) 0.18 | ||
Enterprise Value to Revenue 0.85 | Enterprise Value to EBITDA 2.3 | Shares Outstanding 84037896 | Shares Floating 40499889 |
Shares Outstanding 84037896 | Shares Floating 40499889 | ||
Percent Insiders 1.12 | Percent Institutions 21.22 |
Upturn AI SWOT
So-Young International Inc
Company Overview
History and Background
So-Young International Inc. was founded in 2013 in China. It has grown to become a leading online platform for medical aesthetic services in China. The company connects users with medical aesthetic service providers, offering information, appointment booking, and post-service reviews. It has experienced significant growth as the demand for cosmetic procedures has increased in China.
Core Business Areas
- Information and Booking Platform: So-Young operates an online platform that provides users with comprehensive information about medical aesthetic procedures, clinics, and doctors. It facilitates appointment booking and serves as a marketplace for medical aesthetic services.
- Advertising Services: The company offers advertising services to medical aesthetic institutions and brands, leveraging its user base and data insights to reach potential customers.
- Other Services: This includes potential for data analytics, premium memberships for institutions, and other value-added services to users and providers.
Leadership and Structure
Information regarding the current leadership team and specific organizational structure of So-Young International Inc. is dynamic and best obtained from their latest SEC filings (e.g., 20-F report) or investor relations website. Generally, it would include a CEO, CFO, and board of directors overseeing strategy and operations.
Top Products and Market Share
Key Offerings
- So-Young Platform (App/Website): The core offering is the online platform facilitating discovery, booking, and reviews of medical aesthetic procedures. It acts as a marketplace. Competitors include other online booking platforms, specialized medical directories, and direct clinic websites. While specific market share for the platform itself is hard to quantify, So-Young is a dominant player in China's online medical aesthetics sector. User numbers are in the millions, and transaction volumes are significant. Revenue is primarily driven by commissions and advertising.
- Advertising and Marketing Solutions for Institutions: Providers pay for visibility and lead generation through the platform. Competitors include general advertising platforms and other specialized healthcare marketing firms. This segment contributes significantly to revenue.
Market Dynamics
Industry Overview
The medical aesthetics industry in China has experienced rapid growth, driven by increasing disposable incomes, a growing middle class, and a shift in societal attitudes towards cosmetic procedures. The industry is characterized by a fragmented market of service providers and a growing demand for online information and booking services.
Positioning
So-Young is a leading online platform in China's medical aesthetics market. Its competitive advantages lie in its large user base, extensive network of service providers, brand recognition, and data insights. It acts as a crucial intermediary, aggregating demand and supply.
Total Addressable Market (TAM)
The TAM for the medical aesthetics market in China is substantial and projected to continue growing. So-Young is well-positioned to capture a significant portion of this TAM through its online platform by connecting a vast number of users with a diverse range of service providers. Precise TAM figures are subject to ongoing market research and can vary based on definitions.
Upturn SWOT Analysis
Strengths
- Dominant market position in China's online medical aesthetics sector.
- Large and engaged user base.
- Extensive network of medical aesthetic institutions and doctors.
- Strong brand recognition and user trust.
- Rich user data and insights for targeted services.
Weaknesses
- Reliance on third-party service providers, impacting quality control.
- Regulatory risks associated with the healthcare and aesthetics industry in China.
- Intense competition from existing players and new entrants.
- Potential for platform misuse or fraudulent listings.
- Dependence on the Chinese market.
Opportunities
- Continued growth in the Chinese medical aesthetics market.
- Expansion into related healthcare services or wellness products.
- Leveraging technology (AI, big data) for personalized recommendations and services.
- International expansion or partnerships (though current focus is China).
- Developing value-added services for medical institutions.
Threats
- Changes in government regulations and policies impacting the industry.
- Economic downturns affecting consumer discretionary spending.
- Increased competition from both online and offline players.
- Negative publicity or scandals related to medical malpractice or platform integrity.
- Data privacy and security concerns.
Competitors and Market Share
Key Competitors
- Various online booking platforms in China, though specific US-listed direct comparables in the same niche are limited.
- General healthcare information platforms that might offer some medical aesthetic services.
- Direct booking channels by large aesthetic clinics and hospitals.
Competitive Landscape
So-Young's advantage lies in its early mover status, comprehensive platform, and established brand in the Chinese market. However, it faces competition from numerous smaller, specialized platforms and direct providers, as well as potential shifts in consumer preferences or regulatory frameworks. The fragmented nature of the Chinese market means that while So-Young is a leader, a single dominant player with a majority market share is unlikely.
Growth Trajectory and Initiatives
Historical Growth: So-Young has demonstrated substantial historical growth, driven by the burgeoning demand for medical aesthetics in China and its successful platform strategy. This growth has been characterized by increasing user acquisition, transaction volumes, and revenue expansion.
Future Projections: Future growth projections for So-Young would typically be based on analyst estimates, considering factors like market penetration, new service offerings, and regulatory environments. These projections are subject to change and should be viewed with caution.
Recent Initiatives: Recent initiatives might include efforts to enhance user experience, expand service categories, strengthen partnerships with key institutions, and invest in technology for better service matching and quality assurance. Specific initiatives are best found in company press releases and investor updates.
Summary
So-Young International Inc. is a leading online platform for medical aesthetics in China, capitalizing on a rapidly growing market. Its strengths include a large user base and strong brand recognition. However, it faces regulatory risks and intense competition. Continued growth depends on its ability to maintain user engagement, navigate the regulatory landscape, and differentiate its service offerings in a dynamic market.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (e.g., 20-F, 10-Q)
- Reputable Financial News and Analysis Websites
- Industry Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market conditions are subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About So-Young International Inc
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2019-05-02 | Co-Founder, CEO, Interim CFO & Chairman Mr. Xing Jin | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1800 | Website https://www.soyoung.com |
Full time employees 1800 | Website https://www.soyoung.com | ||
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive and minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems, and hydrodynamic-assisted liposuction systems, as well as pneumatic liquid spray devices. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Chaoyang, China.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

